Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of D-amphetamine on Reward Functioning
NCT03369015Phase 1Completed
- Sponsor
- UTHealth Houston
- Start
- Jan 2018
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dextroamphetamine in anhedonia ((none)) (6 arms), sponsored by UTHealth Houston. Primary endpoints: Reward motivation as assessed by the Effort Expenditure for Reward Task (EEfRT) and Reward learning as assessed by the Probabilistic Reward Task (PRT). Started Jan 2018; status: completed.
02
Drugs
dextroamphetamine
03
Conditions
anhedonia ((none))
Beyond the preview
Go deeper on NCT03369015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03369015.